
Neglected Zoonoses and Antimicrobial Resistance
Impact on One Health and Sustainable Development Goals
- 1st Edition - November 16, 2024
- Imprint: Academic Press
- Editors: Indranil Samanta, Samiran Bandyopadhyay, Olivier Sparagano
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 1 6 0 6 2 - 2
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 6 0 6 3 - 9
Neglected Zoonoses and Antimicrobial Resistance: Impact on One Health and Sustainable Development Goals provides a thorough examination of how neglected zoonoses and antimicro… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quoteNeglected Zoonoses and Antimicrobial Resistance: Impact on One Health and Sustainable Development Goals provides a thorough examination of how neglected zoonoses and antimicrobial resistance together hinder the achievement of sustainable development goals declared by the United Nations in the pursuit of a disease-free world. Neglected zoonotic diseases, as defined by the World Health Organization, are diseases likely to impact the livelihoods of livestock keepers and those living in periurban communities in developing countries. This book examines how such zoonoses affect the health of vulnerable farming populations and reduce the production capacity of their livestock.
Written by internationally recognized experts in the field of livestock and poultry zoonoses, this book provides the reader with a comprehensive description of modern sustainable development goals and defines neglected zoonotic diseases and their impacts on human physical, mental, social, and economic health. Subsequent chapters systematically describe the epidemiology, hosts and transmission, disease process, economic significance, and prevention and treatment protocols of key neglected zoonotic diseases, including echinococcosis, leishmaniasis, zoonotic tuberculosis, anthrax, brucellosis, leptospirosis, borreliosis, rickettsioses, and rabies. The book concludes with an assessment of the obstacles to achieving Sustainable Development Goals and possible mitigation strategies for veterinary researchers and policymakers alike.
- Compiles novel and updated research on pathogens, disease processes, clinical symptoms, diagnostic techniques, vaccines, and treatment protocols
- Covers key neglected zoonotic diseases, including echinococcosis, leishmaniasis, zoonotic tuberculosis, anthrax, brucellosis, leptospirosis, borreliosis, rickettsioses, and rabies
- Examines the relationship between neglected zoonoses and antimicrobial resistance
- Discusses how ineffective research and treatment of neglected zoonoses hinders the achievement of sustainable development goals
- Title of Book
- Cover image
- Title page
- Table of Contents
- Copyright
- Dedication
- Contributors
- About the editors
- Preface
- Chapter 1. Sustainable Development Goal
- 1 Sustainable Development Goals
- 2 Origin of SDG: Transition from MDG
- Chapter 2. Neglected zoonotic diseases
- 1 Introduction
- 1.1 Understanding neglected zoonotic diseases
- 1.2 Impact and consequences
- 2 Conclusion
- Chapter 3. Neglected cystic and alveolar echinococcosis
- 1 Public health relevance, risk factors, taxonomy, and genetic variation
- 1.1 Public health relevance
- 1.2 Risk factors
- 1.3 Taxonomy and genetic variation
- 2 Biology and ecology of E. multilocularis and E. granulosus s.l.
- 2.1 Life cycles of Echinococcus granulosus sensu lato complex
- 2.2 Life cycle of Echinococcus multilocularis
- 2.3 Infectivity, pathogenicity, and parasite–host interactions
- 3 Epidemiology of cystic and alveolar echinococcosis
- 3.1 Global distribution of cystic echinococcosis
- 3.2 Global distribution of alveolar echinococcosis
- 4 Surveillance and control of cystic and alveolar echinococcosis
- 4.1 Surveillance and control of cystic echinococcosis
- 4.1.1 Targeted control programme for CE
- 4.1.2 Focus on the control options for E. granulosus s.l.
- 4.1.3 Focus on the surveillance options for E. granulosus s.l.
- 4.1.4 Assumptions and ultimate goals for a successful CE control programme
- 4.2 Surveillance and control options for alveolar echinococcosis
- 4.2.1 Surveillance of E. multilocularis in foxes
- 4.2.2 Control of E. multilocularis in foxes
- 5 Diagnosis and clinical management of cystic and alveolar echinococcosis?
- 5.1 Clinical features of human cystic and alveolar echinococcosis
- 5.2 Diagnosis of cystic and alveolar echinococcosis
- 5.2.1 Laboratory diagnosis
- 5.3 Clinical management of cystic and alveolar echinococcosis
- Chapter 4. Cysticercosis: Matter of concern
- 1 Mode of transmission
- 2 Disease process
- 3 Changeover of the traditional clinical symptoms into the current one/epidemiology
- 4 Modern diagnostic techniques
- 5 Treatment protocol
- 6 Antiparasitic resistance
- 7 Prevention and control strategy
- 8 Vaccines used recently or under development
- 9 Conclusion
- Chapter 5. Zoonotic sleeping sickness (Trypanosoma brucei)
- 1 Introduction
- 2 Morphology and life cycle of Trypanosoma brucei
- 3 Circadian disruption by sleeping sickness infection
- 4 Infection and disease course
- 5 Epidemiology, transmission, and risk factors
- 6 Diagnosis
- 7 Treatment and management
- 8 In gambiense-HAT
- 9 In rhodesiense-HAT
- 10 Elimination strategies
- 11 Vector control strategy
- 12 Conclusion
- Chapter 6. Leishmaniasis
- 1 Introduction
- 2 Etiology
- 3 Distribution
- 4 Host species and reservoirs
- 5 Transmission and life cycle
- 6 Pathogenesis
- 7 Clinical features
- 8 Diagnosis
- 9 Treatment
- 9.1 Pentavalent antimonials
- 9.2 Amphotericin B
- 9.3 Pentamidine
- 9.4 Paromomycin
- 9.5 Miltefosine
- 9.6 Sitamaquine
- 9.7 Immunotherapy
- 10 Prevention and control
- 10.1 Personal protection
- 10.2 Chemical control
- 10.3 Environmental modification
- 10.4 Reservoir control
- 10.5 Health education
- 10.6 Vaccines
- Chapter 7. Zoonotic tuberculosis
- 1 Introduction
- 2 Mycobacteria
- 3 The importance of zoonotic tuberculosis
- 4 Pathogenesis, clinical presentation, and pathology
- 5 Diagnostic techniques
- 6 Strategies of TB control and treatment
- 7 Vaccines
- 8 Conclusion remarks
- Chapter 8. Anthrax
- 1 Epidemiological distribution
- 2 Etiology
- 3 Hosts
- 4 Mode of transmission
- 5 Disease process
- 6 Changeover of the traditional clinical symptoms into the current one
- 7 Economic importance
- 8 Modern diagnostic techniques
- 9 Treatment protocol
- 10 Antibacterial resistance
- 11 Prevention and control strategies
- 12 Vaccines used recently or under development
- 13 Conclusion
- Chapter 9. Brucellosis: A neglected zoonosis
- 1 Introduction
- 2 Etiology
- 3 Brucella genome
- 4 Distribution and population at risk
- 5 Socioeconomic impact
- 6 Hosts and mode of transmission
- 7 Risk factors associated with transmission
- 8 Diagnosis
- 9 Control measures
- 10 Conclusion
- Chapter 10. Leptospirosis
- 1 Introduction
- 2 Etiology
- 3 Host range
- 4 Mode of transmission
- 5 Disease process
- 5.1 Leptospiral antigens and their role
- 5.2 Adhesion to the cells and entry
- 5.3 Virulence factors and the host's immune system's evasion
- 5.4 Disease development
- 6 Changeover of the traditional clinical symptoms into the current one
- 6.1 In humans
- 6.2 In animals
- 6.2.1 Cattle
- 6.2.2 Buffalo
- 6.2.3 Sheep
- 6.2.4 Goat
- 6.2.5 Swine
- 6.2.6 Horses and other pack animals
- 6.2.7 Dog
- 6.2.8 Cat
- 7 Economic importance
- 8 Treatment protocol
- 8.1 In humans
- 8.2 In animals
- 9 Antibacterial resistance
- 10 Prevention and control strategy
- 11 Vaccines used recently or under development
- 11.1 Bacterins
- 11.2 Attenuated vaccines
- 11.3 LPS-depleted vaccines
- 11.4 Recombinant protein vaccines
- 11.5 Recombinant subunit vaccine
- 11.6 DNA vaccines
- 12 Conclusion
- Chapter 11. Relapsing fever borreliosis
- 1 Introduction
- 2 History
- 3 Distribution
- 3.1 Africa
- 3.2 Asia and Eurasia
- 3.3 Europe
- 3.4 The Americas
- 4 Epidemiology
- 4.1 Louse-borne relapsing fever
- 4.2 Tick–borne relapsing fever
- 5 Etiology
- 6 Hosts
- 6.1 Rodents
- 6.2 Avians
- 6.3 Bats
- 6.4 Livestock and other animals
- 7 Mode of transmission
- 8 Disease process
- 8.1 Vector–Borrelia interactions
- 8.2 Host interactions
- 9 Changeover of the clinical symptoms
- 10 Economic importance
- 11 Classical and modern diagnostic techniques
- 11.1 Microscopical examination
- 11.2 Serological methods
- 11.3 In vitro cultivation
- 11.4 Polymerase chain reaction
- 11.5 LTT, MELISA, and ELISpot tests
- 11.6 Luminex-based, Immuno-PCR techniques
- 12 Treatment protocol and antibacterial resistance
- 12.1 Louse-borne relapsing fever
- 12.2 Tick-borne relapsing fever
- 12.3 Additional considerations
- 13 Prevention and control strategies
- 13.1 Louse-borne RF
- 13.2 Tick-borne RF
- 14 Vaccines
- Chapter 12. Rickettsioses
- 1 Introduction
- 2 Distribution and epidemiology
- 3 Etiology
- 4 Hosts
- 5 Mode of transmission
- 6 Pathogenesis
- 7 Clinical manifestations
- 7.1 Rickettsioses syndrome with a low probability of inoculation eschar
- 7.2 Rickettsioses syndrome with a probability of inoculation eschar
- 8 Economic importance
- 9 Diagnosis
- 10 Treatment
- 10.1 Antibacterial resistance
- 11 Prevention and control
- 11.1 Vaccines used recently or under development
- Chapter 13. Rabies
- 1 Introduction
- 2 Etiology
- 3 Host
- 4 Modes of transmission
- 5 Disease process
- 6 Incubation period
- 7 Epidemiology
- 8 Clinical manifestation of rabies
- 9 Changeover of traditional clinical symptoms into current ones
- 10 Economic importance of rabies
- 11 Diagnosis
- 12 Prevention and control strategy
- 12.1 Prevention and control in animals
- 12.2 Prevention and control in humans
- 13 Treatment protocol
- 14 Vaccines used recently or under development
- 14.1 Vaccines for use in domestic animals
- 14.2 Vaccines for use in wild animals
- 14.3 Vaccines for use in humans
- 15 How rabies control is related to sustainable development goals?
- 16 Some neglected but significant issues in rabies control
- 16.1 Rabies in wildlife and its possible role in spillover to domestic animals and humans
- 16.2 Role of waste management on stray dog population management and rabies control
- 16.3 Influence of socioeconomic factors in the control of rabies
- 16.4 Role of epidemiological modeling techniques in rabies prevention and control
- 16.5 Lack of inclusion of PrEP in human immunization programs
- 17 Conclusions
- Acknowledgments
- Chapter 14. Zoonotic antimicrobial resistance: Impact on human and animal health
- 1 Definition
- 2 Characteristics
- 3 Correlation with neglected zoonotic diseases
- 4 Impact on animal health
- 5 Impact on human health
- Chapter 15. Dual obstacles to sustainable development goals
- 1 How NZDs affect SDGs?
- 2 What an antimicrobial resistance affects SDG?
- Chapter 16. Mitigation strategy for neglected zoonotic diseases and antimicrobial resistance
- 1 Introduction
- 2 Mitigation strategies
- 2.1 Food-borne-related NZDs
- 2.2 Human and anthropogenic factors
- 2.3 Environmental factors
- 3 Antimicrobial resistance
- 4 Conclusion
- Index
- Edition: 1
- Published: November 16, 2024
- Imprint: Academic Press
- No. of pages: 370
- Language: English
- Paperback ISBN: 9780443160622
- eBook ISBN: 9780443160639
IS
Indranil Samanta
SB
Samiran Bandyopadhyay
OS
Olivier Sparagano
Dr. Olivier Sparagano is a Professor at the City University of Hong Kong. He received his MS from the University of Paris VII and his PhD from the Institute Pasteur and the University Lyon I. Prior to his current position, he was the Associate Pro-Vice-Chancellor for Research at Coventry University. He has been researching animal diseases, zoonotic pathogens, and vector-borne issues for more than two decades. His research focuses on poultry mites, ticks, mosquitoes, and other arthropod vectors and vector-borne-pathogens.